Gene · 5771
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loop dynamics, allostery, and function in protein tyrosine phosphatases: insights from molecular simulations. | Biochem Soc Trans | 2026 | 41562625 | PubTator, text mining | PubMed |
| New pathogenic PTPN2 variant leading to childhood interstitial lung disease. | Thorax | 2026 | 41545210 | PubTator, text mining | PubMed |
| Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer Treatment. | ACS Med Chem Lett | 2026 | 41531968 | PubTator, text mining | PubMed |
| Mapping of PTP1B, TCPTP, SHP2, and Putative Substrates Reveals Novel Networks in Glomerular Podocytes. | J Cell Physiol | 2026 | 41520218 | PubTator, text mining | PubMed |
| Genotype subtyping approach to identify unnoticed variants in diseases from GWAS data. | BioData Min | 2026 | 41519843 | PubTator, text mining | PubMed |
| Beyond Bulk Metabolomics: Emerging Technologies for Defining Cell-Type Specific Metabolic Pathways in Health and Disease. | Biomolecules | 2025 | 41463343 | PubTator, text mining | PubMed |
| Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment. | Curr Rheumatol Rep | 2025 | 41410901 | PubTator, text mining | PubMed |
| The synergistic pathogenic mechanism of Brucella melitensis M5-90 effector protein BspC in regulating host cell apoptosis, inflammation and oxidative stress. | J Med Microbiol | 2025 | 41348573 | PubTator, text mining | PubMed |
| A powerful bioorthogonal toolbox boosting the development of immune theranostics. | Chem Sci | 2025 | 41262343 | PubTator, text mining | PubMed |
| Targeting Protein Tyrosine Phosphatase Nonreceptor Type 2 with a Novel Inhibitor for the Treatment of Melanoma. | J Med Chem | 2025 | 41204903 | PubTator, text mining | PubMed |
| 18p Deletion Syndrome Associated with Type 1 Diabetes and Hashimoto's Thyroiditis: A Case Report on Autoimmune Disorders and Genetic Factors. | J Clin Res Pediatr Endocrinol | 2025 | 41194499 | PubTator, text mining | PubMed |
| Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models. | Sci Transl Med | 2025 | 41160667 | PubTator, text mining | PubMed |
| Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition. | iScience | 2025 | 41142999 | PubTator, text mining | PubMed |
| Spatiotemporally delivery of Cas9 ribonucleoprotein/DNAzyme logic systems using near-infrared upconversion nanomachine for precise immunotherapy. | Acta Pharm Sin B | 2025 | 41132842 | PubTator, text mining | PubMed |
| Development of Novel PTPN2/1 Inhibitors for the Treatment of Melanoma. | J Med Chem | 2025 | 41047545 | PubTator, text mining | PubMed |
| Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease' patients. | Front Endocrinol (Lausanne) | 2025 | 41019340 | PubTator, text mining | PubMed |
| PTPN2 acts as a tumor suppressor and therapeutic target in ovarian cancer. | Biochem Biophys Res Commun | 2025 | 41005284 | PubTator, text mining | PubMed |
| PTPN2-KO CAR-T Cells Demonstrate Enhanced Effector Function, CNS Infiltration, and Toxicity in a Non-Human Primate CAR-T Model. | bioRxiv | 2025 | 41000930 | PubTator, text mining | PubMed |
| In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma. | Nature | 2025 | 40993381 | PubTator, text mining | PubMed |
| The type 1 diabetes candidate genes PTPN2 and BACH2 regulate the IFN-α-induced crosstalk between JAK/STAT and MAPKs pathways in human beta cells. | EBioMedicine | 2025 | 40966855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5771/papers?page=3